Circulating tumor DNA (ctDNA) monitoring of estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) high r Published Date January 2, 2024 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen